Compare Dr. Reddys with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs WYETH LTD - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB WYETH LTD DR. REDDYS LAB/
WYETH LTD
 
P/E (TTM) x 17.8 27.7 64.2% View Chart
P/BV x 3.4 5.3 63.7% View Chart
Dividend Yield % 0.7 1.3 54.4%  

Financials

 DR. REDDYS LAB   WYETH LTD
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-19
WYETH LTD
Mar-13
DR. REDDYS LAB/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs2,8751,044 275.3%   
Low Rs1,888818 230.8%   
Sales per share (Unadj.) Rs930.2298.6 311.6%  
Earnings per share (Unadj.) Rs117.457.2 205.1%  
Cash flow per share (Unadj.) Rs185.858.4 318.0%  
Dividends per share (Unadj.) Rs20.0017.00 117.6%  
Dividend yield (eoy) %0.81.8 46.0%  
Book value per share (Unadj.) Rs844.4249.5 338.5%  
Shares outstanding (eoy) m166.0722.72 730.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.63.1 82.1%   
Avg P/E ratio x20.316.3 124.7%  
P/CF ratio (eoy) x12.815.9 80.4%  
Price / Book Value ratio x2.83.7 75.6%  
Dividend payout %17.029.7 57.4%   
Avg Mkt Cap Rs m395,49621,157 1,869.3%   
No. of employees `00022.00.5 4,464.6%   
Total wages/salary Rs m33,562400 8,390.5%   
Avg. sales/employee Rs Th7,032.813,787.4 51.0%   
Avg. wages/employee Rs Th1,527.9813.0 187.9%   
Avg. net profit/employee Rs Th887.72,643.3 33.6%   
INCOME DATA
Net Sales Rs m154,4826,783 2,277.4%  
Other income Rs m3,375353 957.2%   
Total revenues Rs m157,8577,136 2,212.1%   
Gross profit Rs m31,7821,617 1,965.1%  
Depreciation Rs m11,34827 42,661.7%   
Interest Rs m8896 16,163.6%   
Profit before tax Rs m22,9201,938 1,182.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m4380-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m3,858632 610.2%   
Profit after tax Rs m19,5001,301 1,499.4%  
Gross profit margin %20.623.8 86.3%  
Effective tax rate %16.832.6 51.6%   
Net profit margin %12.619.2 65.8%  
BALANCE SHEET DATA
Current assets Rs m111,1016,984 1,590.8%   
Current liabilities Rs m58,9732,056 2,868.5%   
Net working cap to sales %33.772.6 46.4%  
Current ratio x1.93.4 55.5%  
Inventory Days Days7999 79.9%  
Debtors Days Days9424 393.5%  
Net fixed assets Rs m101,245244 41,442.9%   
Share capital Rs m830227 365.3%   
"Free" reserves Rs m139,4065,441 2,562.2%   
Net worth Rs m140,2365,668 2,474.2%   
Long term debt Rs m22,00025 88,000.0%   
Total assets Rs m224,6567,901 2,843.4%  
Interest coverage x26.8353.3 7.6%   
Debt to equity ratio x0.20 3,556.7%  
Sales to assets ratio x0.70.9 80.1%   
Return on assets %9.116.5 54.9%  
Return on equity %13.922.9 60.6%  
Return on capital %14.934.0 43.9%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m88,67315 583,375.0%   
Fx outflow Rs m19,1042,677 713.6%   
Net fx Rs m69,569-2,662 -2,613.4%   
CASH FLOW
From Operations Rs m28,704923 3,109.2%  
From Investments Rs m-7,727317 -2,438.3%  
From Financial Activity Rs m-21,326-481 4,433.7%  
Net Cashflow Rs m-314759 -41.4%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 5.4 11.3 47.8%  
FIIs % 35.3 7.2 490.3%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 30.4 50.3%  
Shareholders   75,885 21,978 345.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   FDC LTD.  UNICHEM LAB  CIPLA  AJANTA PHARMA  ALEMBIC LTD  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 172 Points Higher; IT and Power Stocks Witness Buying(Closing)

Indian share markets continued to trade on a positive note during closing hours and ended their session near day's high.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (1QFY19); Net Profit Up 614.9% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 614.9% YoY). Sales on the other hand came in at Rs 37 bn (up 12.1% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Dec 11, 2019 03:35 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - FULFORD INDIA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS